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Abstract
All organisms usually isolated in our laboratory are now routinely identiﬁed by matrix-assisted laser desorption ionization–time of ﬂight
mass spectrometry (MALDI-TOF MS) using the Andromas software. The aim of this study was to describe the use of this strategy in a
routine clinical microbiology laboratory. The microorganisms identiﬁed included bacteria, mycobacteria, yeasts and Aspergillus spp. iso-
lated on solid media or extracted directly from blood cultures. MALDI-TOF MS was performed on 2665 bacteria isolated on solid
media, corresponding to all bacteria isolated during this period except Escherichia coli grown on chromogenic media. All acquisitions
were performed without extraction. After a single acquisition, 93.1% of bacteria grown on solid media were correctly identiﬁed. When
the ﬁrst acquisition was not contributory, a second acquisition was performed either the same day or the next day. After two acquisi-
tions, the rate of bacteria identiﬁed increased to 99.2%. The failures reported on 21 strains were due to an unknown proﬁle attributed
to new species (9) or an insufﬁcient quality of the spectrum (12). MALDI-TOF MS has been applied to 162 positive blood cultures. The
identiﬁcation rate was 91.4%. All mycobacteria isolated during this period (22) were correctly identiﬁed by MALDI-TOF MS without
any extraction. For 96.3% and 92.2% of yeasts and Aspergillus spp., respectively, the identiﬁcation was obtained with a single acquisition.
After a second acquisition, the overall identiﬁcation rate was 98.8% for yeasts (160/162) and 98.4% (63/64) for Aspergillus spp. In conclu-
sion, the MALDI-TOF MS strategy used in this work allows a rapid and efﬁcient identiﬁcation of all microorganisms isolated routinely.
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Introduction
MALDI-TOF MS (matrix-assisted laser desorption ionization–
time of ﬂight mass spectrometry) generates a spectrum based
on proteins detected directly from intact microorganisms,
allowing a rapid identiﬁcation. Numerous papers have evalu-
ated separately the identiﬁcation by MALDI-TOF MS of speciﬁc
categories of microorganisms by comparing the use of MALDI-
TOF databases with phenotypic or molecular techniques [1–9].
The identiﬁcation is possible by comparing the spectra of the
sample with that of reference databases. Several databases
exist: Andromas of Andromas SAS (Paris, France), Biotyper of
Bruker Daltonics (Bremen, Germany) and Saramis of BioMe´r-
ieux (Marcy l’Etoile, France). In recent months, several studies
using the databases Biotyper and Saramis have already
reported the use of MALDI-TOF MS for bacterial and/or yeast
identiﬁcation in routine clinical microbiology [7,10–19].
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The Andromas database was engineered using an original
strategy based on the identiﬁcation of a limited number of
species-speciﬁc peaks for each entry [6,20]. This database
has been evaluated during 1 year for all microorganisms cul-
tivated in solid or liquid media (bacteria, Aspergillus spp.,
yeasts and mycobacteria). During this period, the MALDI-
TOF identiﬁcations of all microorganisms isolated in routine
practice were compared with the conventional technique
and molecular biology. Several reports have already been
published for some groups of bacteria: Staphylococcus spp.
[4,21], non-fermented negative Gram rods [6], mycobacteria
[3], Aspergillus spp. [8] and microorganisms grown in blood
culture bottles [22]. After this evaluation, this technique has
been implemented routinely to identify all microorganisms
isolated in the clinical microbiology laboratory of the
Necker-Enfants Malades hospital.
We report here the use of this database for the identiﬁca-
tion of all organisms (bacteria, mycobacteria, yeasts and
Aspergillus spp. isolated on solid media or extracted directly
from blood cultures) routinely isolated in clinical microbiol-
ogy laboratories.
Materials and Methods
Organisms
Between 1 June and 31 July 2010, all microorganisms isolated
in our laboratory, except Escherichia coli grown on chromo-
genic media and ﬁlamentous fungi other than Aspergillus spp.,
were identiﬁed by MALDI-TOF MS, including 2665 bacteria
grown on any standard media used in our laboratory, 162
positive blood cultures performed without charcoal, 162
yeasts, 64 Aspergillus spp. and 22 mycobacteria.
Sample preparation for microorganisms grown on solid
media
The sample preparation procedure was recommended by
Andromas SAS.
Bacteria. Part of a fresh colony (18 to 48 h) from any selec-
tive (i.e. cetrimide agar, mannitol salt agar, media containing
antibiotics, etc.) and non-selective solid media (i.e. blood
agar, chocolate agar + polyvitex, etc.) was deposited on one
well of a target plate (Bruker Daltonics) [6,20]. After drying,
1 lL of absolute ethanol was added onto each well
(optional).
Fungi. Part of a yeast colony or the superﬁcial material of an
Aspergillus colony (spores, conidiophores and mycelium) was
collected and mixed with 1 lL of 70% formic acid previously
deposited on the target plate in two replicates and allowed
to dry at room temperature [8].
Mycobacteria. For each mycobacterial strain, several colonies
grown in the mycobacterial medium Lo¨wenstein-Jensen (LJ)
were harvested in 40 lL of 70% ethanol. This suspension
was stored at room temperature for 10 min, deposited in
ﬁve replicates on a target plate and allowed to dry [3].
For all microorganisms, 1 lL of matrix solution was added
to the sample. The matrix solution was HCCA (saturated
solution of cyano-4-hydroxycinnamic acid in acetonitrile 50%,
triﬂuoroacetic acid 2.5%) for bacteria and fungi, and SA (sin-
apinic acid 20 mg/mL, acetonitrile 30%, triﬂuoroacetic acid
10%) for mycobacteria.
Sample preparation from blood cultures
Blood culture preparation was described previously [22].
Brieﬂy, 200 lL of the blood culture broth were mixed with
40 lL of a 5% saponin solution to release intracellular bacte-
ria. After 5 min of incubation at room temperature, distilled
water was added up to 1.8 mL and two consecutive washes
were performed at 16 600 g for 1 min. The supernatant was
discarded and 5 lL of 10% triﬂuoroacetic acid was added to
the pellet. This protocol required < 15 min. Then, 1 lL of
this mixture was spotted in two replicates on a target plate
and, once dry, 1 lL of absolute ethanol was added (optional)
followed by 1 lL of HCCA matrix solution. We used etha-
nol during the study because it theoretically reduces the risk
of environmental contamination, but we believe now that
this step is not necessary.
MALDI-TOF MS acquisition
Target plates were processed in the MALDI-TOF MS spec-
trometer Microﬂex (Bruker Daltonics) with the ﬂex con-
trol software (Bruker Daltonics). Positive ions were
extruded with an accelerating voltage of 20 kV in linear
mode. Each spectrum was the sum of 50 shots performed
in six different regions on the same well. The spectrum
was analysed in an m/z range of 3640–19 055 using the
ﬂex analysis software (Bruker Daltonics) and calibrated
with the protein calibration standard I (Bruker Daltonics).
Numerical data obtained from the spectrometer (peak
value and relative intensity for each peak) were analysed
using the Andromas software (version 2010). Two other
controls were added on each bacterial target plate: a strain
of Pseudomonas aeruginosa (ATCC 76110) used as a calibra-
tion and a strain of Enterococcus faecium (clinical strain
identiﬁed by molecular biology) used as a control of the
quality of the acquisition.
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Andromas identiﬁcation strategy
The Andromas software includes three separate databases:
bacteria, yeasts and Aspergillus spp., and mycobacteria. Each
entry has been chosen for its medical interest and, in most
cases, was obtained from a clinical strain identiﬁed by molec-
ular biology. For each strain chosen to implement the data-
base, 10 replicates were performed, and peaks with an
intensity higher than 7% of the highest peak of the spectrum
were conserved and arbitrarily considered as being species-
speciﬁc peaks. To increase the robustness of this method,
several entries per species have been implemented. These
various entries could correspond either to proﬁles of the
same strain grown on different culture media (chromogenic
for example) or to different strain proﬁles of the same spe-
cies. The Andromas software is also equipped with an expert
system to overcome as much as possible the acquisition
problems linked to primary cultures and/or overgrown
colonies.
For each sample, a barcode is assigned, including the data-
base to be queried and some characteristics of the microor-
ganisms to identify, such as the morphological aspect (cocci
or bacilli) and the Gram stain. The results of the Andromas
software are given as a percentage of similarity between the
sample spectrum and a database reference spectrum. These
results are classiﬁed in three categories: ‘good identiﬁcation’,
‘identiﬁcation to be conﬁrmed’ (using a second acquisition)
and ‘no identiﬁcation’.
A ‘good identiﬁcation’ was given if the percentage was at
least 65% of similarity with the reference with a difference
between the ﬁrst two species of at least 10%; therefore all
‘good identiﬁcation’ were given at the species level. ‘Identiﬁ-
cation to be conﬁrmed’ was for a percentage of similarity
between 60 and 64%. A percentage below 59% or a differ-
ence < 10% between the ﬁrst two proposed species was in
the ‘no identiﬁcation’ category. In cases of ‘identiﬁcation to
be conﬁrmed’ or ‘no identiﬁcation’, a new acquisition was
performed from a new spotting, either the same day or the
next day with bacteria obtained from the antibiotic suscepti-
bility testing plate.
For bacteria identiﬁed directly from positive blood culture
bottles, a good identiﬁcation was deﬁned by a percentage of
similarity of at least 60% with a difference between the ﬁrst
two matching species of at least 10%. The lower threshold
compared with that used for bacteria is due to the
decreased quality of spectra [22].
When several spots were used to identify a strain (i.e. for
strains grown in blood culture bottles, yeasts, Aspergillus spp.
and mycobacteria), a good identiﬁcation on at least one well
was considered sufﬁcient. If there were discrepant results
among the multiple spots, the acquisition had to be rerun.
The biologist validated the identiﬁcation by conﬁrming the
good correlation between the identiﬁcation given by the
Andromas software and the microbial phenotypic features
(Gram, culture characteristics and antibiotic susceptibility
proﬁle).
In some circumstances, the Andromas bacterial databases
cannot differentiate between closely related species: Strepto-
coccus pneumoniae from Streptococcus mitis, Streptococcus pyog-
enes from Streptococcus dysgalactiae equisimilis, Escherichia coli
from Shigella, Aeromonas veronii from Aeromonas caviae,
Neisseria subﬂava from Neisseria sicca, Listeria monocytogenes
from Listeria innocua and Listeria ivanovii (the software pro-
vides the result ‘Listeria sp.’). The fungi database cannot
identify the species belonging to the genus Geotrichum. The
mycobacterial database cannot differentiate the species inside
the Mycobacterium tuberculosis complex. To overcome some
of these limitations, simple additional identiﬁcation tests
were performed after the MALDI-TOF MS acquisition. In
cases of no differentiation between S. pneumoniae and
S. mitis, a Slidex pneumo-Kit (BioMe´rieux) is performed. The
differentiation between S. pyogenes and S. dysgalactiae equisim-
ilis is performed by serogrouping with Group A antiserum
ﬁrst, then Group C and G if Group A antiserum doesn’t
react. In the case of a clinical suspicion of Shigella, we used a
serotype agglutination (Biorad, Marnes la Coquette, France)
on colonies.
Other identiﬁcation methods used in this study
If the methodology described above was correctly performed
twice but did not yield a ‘good identiﬁcation’, the identiﬁca-
tion was performed using phenotypic strips (bioMe´rieux) or
by sequencing of the 16S rRNA gene (anaerobes and Gram
positive bacilli), the cpn60 gene (Aeromonas spp.), the sodA
gene (Staphylococcaceae), the rpoB gene (Streptococcacae, En-
terobacteriaceae and Acinetobacter spp.) [23–25], the rRNA
internal spacer region ITS1-5.8S-ITS2 rRNA genes (yeasts)
[26] and the b-tubulin and calmodulin genes (Aspergillus spp.)
[27]. These biological molecular techniques have also been
used to identify the clinical strains included in the database.
Results
Identiﬁcation of bacteria from solid media
During 2 months, 2665 identiﬁcations of bacteria using the
above-described procedure were performed. After the ﬁrst
acquisition, we obtained 2482 ‘good identiﬁcations’ (93.1%),
42 ‘identiﬁcations to be conﬁrmed’ (1.6%) and 141 ‘no identiﬁ-
cation’ (5.3%) (Fig. 1a); 35 strains for which the identiﬁcation
was ‘to be conﬁrmed’ were discarded because of the lack of
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clinical relevance (for example, bacteria recovered from the
normal ﬂora of non-sterile body sites) (Fig. 1a). For the 148
remaining bacteria (‘to be conﬁrmed’ and ‘no identiﬁcation’),
another acquisition was performed: a ‘good identiﬁcation’
was obtained for 127 strains (86%), a result ‘identiﬁcation to
be conﬁrmed’ for three strains (2%) and ‘no identiﬁcation’
for 18 strains (12%) (Fig. 1a). Among those 18 strains, nine
did not yield a good enough spectrum, including ﬁve strains
diagnosed at the genus level (three Enterobacteriaceae, one
Aeromonas sp. and one Streptococcus sp.). The nine remaining
isolates corresponded to species not yet included in the
database (Table 1).
Altogether, using the complete strategy (a second run if
necessary), this method allowed a proper identiﬁcation of
bacteria grown on solid media in 99.2% of cases (2609/2630)
(Figs 1 and 2).
Identiﬁcation of bacteria from blood culture
During the study, the identiﬁcation of 162 strains from posi-
tive blood cultures was performed by MALDI-TOF MS.
Among these, 148 extracts (91.4%) were immediately identi-
ﬁed while the 14 remaining were identiﬁed the next day
after subculture on a plate (Table 2, Fig. 1b). Among the 14
strains not identiﬁed directly from the blood cultures, two
corresponded to species not yet included in the database,
three were due to polymicrobial blood cultures and nine
were the consequence of poor quality spectra, including four
strains diagnosed at the genus level (three Staphylococcus sp.
and one Acinetobacter sp.). The subculture on solid media
allowed a good identiﬁcation using MALDI-TOF MS for the
remaining 12 isolates. Altogether, we obtained a good spe-
cies identiﬁcation in 93% of monomicrobial blood cultures.
Identiﬁcation of yeasts
During this period, 162 MALDI-TOF MS identiﬁcations of
yeasts grown on solid media were performed. After the
2665 bacteria from solid media 
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FIG. 1. Results obtained after the ﬁrst and the second acquisition for
(a) bacteria grown on solid media, (b) bacteria from blood culture, (c)
yeasts grown on solid media and (d) Aspergillus spp. on solid media.
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TABLE 1. Identiﬁcation of the 2640
bacteria and 22 mycobacteria
grown on solid media
Groups Species
Good
identiﬁcation
Identiﬁcation
to be conﬁrmed
No
identiﬁcation
Positive Gram cocci Kocuria kristinae 1a
Staphylococcus aureus 446
Staphylococcus auricularis 2
Staphylococcus capitis 12
Staphylococcus caprae 2
Staphylococcus cohnii 3
Staphylococcus croceolyticus 5 1a
Staphylococcus epidermidis 268
Staphylococcus haemolyticus 40
Staphylococcus hominis 53
Staphylococcus lugdunensis 5
Staphylococcus pettenkoferi 1
Staphylococcus saprophyticus 1
Staphylococcus schleiferi 1
Staphylococcus warneri 11
Enterococcus avium 2
Enterococcus faecalis 197 1b
Enterococcus faecium 31 1b
Granulicatella adiacens 1
Streptococcus milleri group 1
Lactococcus lactis 1
Pediococcus acidilactici 1
Streptococcus agalactiae 59 2b 1b
Streptococcus anginosus 6
Streptococcus constellatus 12
Streptococcus dysgalactiae equisimilis 4
Streptococcus intermedius 6
Streptococcus mitis 34 1a
Streptococcus oralis 6
Streptococcus pneumoniae 34
Streptococcus pseudopneumoniae 1
Streptococcus pyogenes 28
Streptococcus salivarius 2
Streptococcus sanguinis 1
Streptococcus vestibularis 1
Streptococus mutans 1
Anaerobes Anaerococcus vaginalis 1
Atopobium vaginae 1a
Bacteroides fragilis 3
Bacteroides thetaiotaomicron 2
Bacteroides uniformis 1
Clostridium difﬁcile 7 1b
Clostridium innocuum 1
Dialister pneumosintes 1a
Fusobacterium necrophorum 1
Parvimonas micra 4
Propionibacterium acnes 2
Propionibacterium avidum 2
Actinomyces graevenitzii 1a
Actinomyces odontolyticus 1
Biﬁdobacterium dentium 1
Negative Gram cocci Moraxella catarrhalis 25
Neisseria subﬂava/sicca 9
Neisseria mucosa 2
Positive Gram bacilli Bacillus simplex 1
Corynebacterium amycolatum 3
Corynebacterium bovis 1
Corynebacterium imitans 1
Corynebacterium jeikeium 3
Corynebacterium pseudodiphteriticum 1
Corynebacterium striatum 2
Corynebacterium sundsvallense 1
Corynebacterium tuberculostearicum 3
Gardnerella vaginalis 4
Lactobacillus gasseri 1
Lactobacillus rhamnosus 2
Turicella otitidis 1
Negative Gram bacilli Achromobacter xylosoxidans 8
Acinetobacter baumannii 16
Acinetobacter haemolyticus 1
Acinetobacter radioresistens 1a
Acinetobacter ursingii 6
Burkholderia complexe cepacia 2
Chryseomonas luteola 1
Comamonas kerstersii 1
Ochrobactrum anthropi 6
Pseudomonas aeruginosa 262
Pseudomonas alcaligenes 2
Pseudomonas ﬂuorescens 5
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ﬁrst acquisition, 155 ‘good identiﬁcation’, one ‘identiﬁcation
to be conﬁrmed’ (96.3%) and six ‘no identiﬁcation’
were obtained (Fig. 1c). After the second acquisition,
ﬁve out of seven good identiﬁcations were obtained.
The two remaining cases corresponded to a species
not included in the database (C. lambica). Altogether,
98.8% of yeasts could be identiﬁed (160/162) (Fig. 1c,
Table 3).
Identiﬁcation of Aspergillus spp.
Sixty-four MALDI-TOF MS identiﬁcations of Aspergillus spp.
grown on solid media were performed, as they were previ-
ously suspected by the biologist to be an Aspergillus spp.
based on the presence of a characteristic conidial head. Fifty-
ﬁve ‘good identiﬁcation’ (86%), four ‘identiﬁcation to be con-
ﬁrmed’ (6%) and ﬁve ‘no identiﬁcation’ (8%) were obtained
after the ﬁrst acquisition. After the second acquisition, 63/64
strains were properly identiﬁed (98.4%) (Table 3, Fig. 1d).
Identiﬁcation of mycobacteria
During the 2 months, 22 MALDI-TOF MS identiﬁcations of
mycobacteria grown on solid media were performed. Among
these, 21 had a ‘good identiﬁcation’ (95.5%). Another acquisi-
tion was performed with the remaining strain with initially
no identiﬁcation and allowed a ‘good identiﬁcation’ (Table 1).
Therefore, all mycobacteria (100%) were correctly identiﬁed
by this method.
Discussion
We reported the identiﬁcation of all microorganisms isolated
in our laboratory during a 2-month period, using the
MALDI-TOF MS Andromas software. The database linked to
this software has been developed using mostly strains of
human clinical interest obtained from various clinical micro-
biology laboratories. This study shows the performance of
TABLE 1. Continued
Groups Species
Good
identiﬁcation
Identiﬁcation
to be conﬁrmed
No
identiﬁcation
Pseudomonas groupe putida 7 1a
Pseudomonas fragi 1a
Pseudomonas stutzeri 1
Ralstonia mannitolilytica 1
Rhizobium radiobacter 1
Sphingobacterium multivorum 1
Sphingobacterium spiritovorum 1
Stenotrophomonas maltophilia 31
Stenotrophomonas sp. 1a
Aeromonas caviae/A. veronii 2 1a
Aggregatibacter aphrophilus 1
Campylobacter coli 1
Campylobacter jejuni 6
Capnocytophaga sputigena 2
Eikenella corrodens 1
Haemophilus inﬂuenzae 64
Haemophilus parainﬂuenzae 5
Haemophilus paraphrohaemolyticus 3
Kingella kingae 2
Citrobacter groupe freundi 72
Citrobacter groupe koseri 30
Enterobacter aerogenes 35 1b
Enterobacter cloacae 128
Enterobacter pulveris 1a
Escherichia coli 157 1b
Hafnia alvei 3
Klebsiella oxytoca 52
Klebsiella pneumoniae 220 1b
Kluyvera georgiana 1
Morganella morganii 22
Pantoea agglomerans 2
Pantoea dispersa 1
Proteus mirabilis 53
Proteus vulgaris 7
Providencia alcalifaciens 1
Providencia rettgeri 2
Raoultella ornithinolytica 1
Salmonella enterica 2
Serratia marcescens 14
Yersinia enterocolitica 1
Total bacteria 2619 3 18
Mycobacteria Mycobacterium chelonae 3
Mycobacterium complexe tuberculosis 1
Mycobacterium mucogenicum 2
Mycobacterium abscessus 16
Total mycobacteria 22
aIdentiﬁed by molecular biology.
bIdentiﬁed by biochemical reactions
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the MALDI-TOF strategy extended to various identiﬁcations:
bacteria, mycobacteria, fungi and blood cultures. It is to date
the fastest method, providing excellent results without prior
extraction. Overall, during the study period, after a single
run of MALDI-TOF MS without extraction, over 90% of
microorganisms (bacteria, yeasts and mycobacteria) from
liquid or solid cultures, were successfully identiﬁed by this
method, and validated by the biologist without additional
phenotypic galleries.
The Andromas software is able to differentiate Aspergillus
species into sections (Fumigati, Flavi and Terrei), in contrast to
the identiﬁcation based on the morphological characteristics
[8].
By doing an additional acquisition when the ﬁrst run did
not yield a correct identiﬁcation, we could increase the rate
of good identiﬁcation up to 98% for all microorganisms cul-
tured in solid media. Unlike other methods that require
extraction steps after an invalid score or for Gram positive
bacteria or fungi [5,10,12,14,19,28,29], the Andromas strat-
egy needs no extraction and a maximum of two acquisitions
was required. These two acquisitions could have been done
initially, as this method is costless, but then there is the dis-
advantage that it requires frequent instrumental maintenance
and has a shorter lifetime of the LASER.
The strategy used in this study for the direct identiﬁca-
tion of bacteria grown in blood culture liquid is much faster
than some of the proposed procedures [7,17,18,30] and
yields a proper identiﬁcation in over 90% of the tested
broths.
As previously mentioned, for bacteria belonging to
very closely related species or the same genospecies, S. pyog-
enes/S. dysgalactiae [31], E. coli/Shigella [32] and S. pneumo-
niae/S. mitis [33], MALDI-TOF MS can only provide a
result between two possible identiﬁcations. This limitation
of MALDI-TOF MS was reported by other authors
[13,15,17,30].
The Slidex pneumokit test was applied to all the strains
displaying a ‘S. pneumoniae/S. mitis’ result by MALDI-TOF MS.
All S. pneumoniae identiﬁcations were conﬁrmed by the
optochin test the next day. No supplementary test was used
for E. coli and Shigella, as no suspicion of Shigella was noted
during the study.
No supplementary tests to differentiate the non-patho-
genic Neisseria subﬂava from N. sicca were implemented, as
their identiﬁcations are not relevant in clinical routines.
The low number of non-identiﬁed microorganisms sug-
gests that the database contains the majority of bacteria
encountered in human pathology. However, the differentia-
TABLE 2. Identiﬁcation of bacteria
grown in blood culture bottles Groups Species
Good identiﬁcation
at the species level
No
identiﬁcation
Positive Gram cocci Micrococcus luteus 1
Staphylococcus aureus 17 2
Staphylococcus capitis 1
Staphylococcus epidermidis 51 3
Staphylococcus haemolyticus 6 2
Staphylococcus hominis 15
Staphylococcus hominis +
Staphylococcus epidermidis
1
Staphylococcus lugdunensis 3
Streptococcus pyogenes +
Staphylococcus aureus
1
Granulicatella adiacens 1
Streptococcus agalactiae 1
Streptococcus constellatus 1
Streptococcus mitis 4
Streptococcus pneumoniae 1
Streptococcus thermophilus 1
Positive Gram bacilli Actinomyces georgiae 1
Actinomyces graevenitzii 1
Corynebacterium bovis 1
Corynebacterium imitans 1
Mycobacterium mucogenicum 1
Negative Gram bacilli Pseudomonas aeruginosa 4
Pseudomonas alcaligenes 1
Pseudomonas ﬂuorescens 1
Rhizobium radiobacter 1
Capnocytophaga sputigena 1 1
Haemophilus inﬂuenzae 1
Enterobacter aerogenes 1
Enterobacter cloacae 7
Escherichia coli 16
Escherichia coli + Enterobacter cloacae 1
Klebsiella pneumoniae 6
Proteus mirabilis 4
Total 148 14
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tion between closely related species mentioned in ‘Material
and methods’ is to be improved.
A cost-study performed during this period showed that,
even if one includes the cost of the instrument and its bian-
nual maintenance, the MALDI-TOF identiﬁcation is ﬁve times
less expensive than biochemical galleries. For each microor-
ganism, the turnaround times from the colony or the culture
until the identiﬁcation result using the Andromas Software
were < 10 min (bacteria and fungi), 20 min (mycobacteria)
and 15 min (blood cultures).
In conclusion, MALDI-TOF MS associated with the Andro-
mas strategy allows a very rapid, inexpensive and efﬁcient
identiﬁcation of all microorganisms isolated under routine
conditions in microbiological laboratories, whatever the cul-
ture medium used. The good results were obtained despite
the large number of technicians who used this method. It
would be interesting to test these performances with those
of other strategies in a comparative trial.
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